SYROS PHARMACEUTICALS, INC. Deferred Revenue
SYROS PHARMACEUTICALS, INC. had Deferred Revenue of $139.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2024-03-27
- 2023-09-30: Deferred Revenue, Current $139.00K.
- 2023-06-30: Deferred Revenue, Current $2.19M.
- 2023-03-31: Deferred Revenue, Current $3.25M.
- 2022-12-31: Deferred Revenue, Current $4.33M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-09-30 | $139.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.19M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.25M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $4.33M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.63M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.59M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.77M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $10.18M 10-K · filed 2023-03-02 |
| 2021-09-30 | $11.99M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $12.12M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $12.79M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $12.21M 10-K · filed 2022-03-15 |
| 2020-09-30 | $11.18M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.08M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.79M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.74M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.11M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.66M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.85M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $1.93M 10-K · filed 2020-03-05 |
| 2016-12-31 | $550.00K 10-K · filed 2018-03-12 |